Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Colorectal Cancer

Clinical trial condition

Metastatic Colorectal Cancer

Explore clinical trials studying Metastatic Colorectal Cancer. Study availability and eligibility vary by location and protocol.

386 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Colorectal Cancer trial results

Completed

Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer

NCT00378066

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: National Cancer Center Goyang, South Korea

Asan Medical Center Seoul, South Korea

Samsung Medical Center Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Intermittent Versus Continuous Tarceva Study

NCT01243047

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

View Trial Details

Completed

Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors

NCT00910676

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations: Centre Oscar Lambret Lille, France

Centre Hospitalier Regional Lille, France

Centre Hospitalier Régional Lille, France

View Trial Details

Completed

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

NCT01053104

Conditions: Breast Diseases, Breast Neoplasms, Colonic Diseases, +18 more
Locations: Oxford Cancer Centre, Churchill Hospital Oxford, United Kingdom

View Trial Details

Completed

Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)

NCT00862342

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Asan Medical Center Seoul, Songpa-gu, South Korea

View Trial Details

Completed

Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations

NCT00792363

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Vejle Hospital, Dept. of Oncology Vejle, Denmark

View Trial Details

Completed

Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer

NCT00286130

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: LKH Leoben, Abt. für Innere Medizin Leoben, Styria, Austria

Univ. Klinik für Innere Medizin I Vienna, Austria

Institute of Oncology Sarajevo, Bosnia and Herzegovina

University Hospital "Queen Joanna" Sofia, Bulgaria

View all 27 locations

View Trial Details

Completed

Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer

NCT01387880

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Herlev University Hospital Herlev, Copenhagen, Denmark

View Trial Details

Completed

First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer

NCT01437618

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Azienda Ospedaliero-Universitaria Pisana Pisa, Italy

View Trial Details

Completed

1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.

NCT00345696

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Hospital 12 de Octubre Madrid, Spain

View Trial Details